Abstract
The first part of the survey is dedicated to the current status of the large scale production of Β-IFN, intended for extensive and significant clinical trials. In particular, the methods employed for the growth of human foreskin fibroblasts and the induction and purification of the active molecule are reviewed.
The second part is dedicated to the detailed description of the only plant operating in Italy, producing clinical grade IFN. Special emphasis is given to the control methodologies adopted for the registration of the product.
Finally, some consideration is given to the present state of the art and the future trends in the field of Β-IFN production.
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- Con-A:
-
concanavaiin-A
- CPG:
-
controlled pore glass
- DMEM:
-
Dulbecco's modified Earle medium
- EG:
-
ethylen glycol
- FBS:
-
fetal calf serum
- HEPA:
-
high efficiency particulate air
- IFN:
-
interferon
- IU:
-
international unit
- pCO2 :
-
dissolved carbon hydroxide pressure
- pO2 :
-
dissolved oxigen pressure
- PDL:
-
population doubling level
- RB:
-
roller bottle
- SF:
-
spinner flask
- T:
-
temperature
References
Youngner, J. S., Stinebring, W. R., Taube, S. E.: Virology 27, 541 (1965)
Vilcek, J., Rossman, T. G., Varacalli, F.: Nature 222, 682 (1969)
Vilcek, J.: Ann. N.Y. Acad. Sci. 173, 390 (1970)
Tan, Y. H., Armstrong, J. A., Ke, J. H., Ho, M.: Proc. Natl. Acad. Sci. U.S.A. 67, 464 (1970)
Havell, E. R., Vilcek, J.: Antimicro. Ag. Chemother. 2, 476 (1972)
Billiau, A., Joniau, M., De Somer, P.: J. Gen. Virol. 19, 1 (1973)
Committee on Interferon Nomenclature Nature, 286, 110 (1980)
Jacobs, J. P.: Serially-propagated human diploid cell: a synopsis of the present position concerning their use for producing viral vaccines and interferon, in: Develop. Biol. Standard. 42, (ed. Inter. Assoc. Biol. Standard.) p. 13, Basel, S. Karger 1978
Derynck, R., Content, J., De Clercq, E., Volckaert, G., Tavernier, J., Devos, R., Fiers, W.: Nature, 285, 542 (1980)
Taniguchi, T., Ohno, S., Takaoka, C.: Expression of the cloned genes for human interferon Β 1 in E. coli and cultural mouse cells, in: Interferons, UCLA Symposia on molecular and cellular biology, 25 (eds. Merigan, T. and Friedman, R.) p. 15, New York, Academic Press 1982
Goeddel, D. V., Shepard, H. M., Yelverton, E., Leung, D., Crea, R.: Nucleic Acids Res. 8, 4057 (1980)
Ohno, S., Taniguchi, T.: Nucleic Acid Res. 10, 967 (1982)
Utsumi, J., Itzuka, M., Kobayashi, S.: J. of Interf. Research 4, 9 (1984)
Jankowsky, W. J., Davey, M. W., O'Malley, J. A., Sulkowsky, E., Carter, A.: J. Virol. 16, 1124 (1975)
Gheysen, D., Fiers, W.: J. Mol. Appl. Genet. 1, 385 (1982)
Cannaani, D., Berg, P.: Proc. Natl. Acad. Sci. U.S.A. 79, 5166 (1982)
McCormik, F., Trahey, M., Innis, M., Dieckmann, B., Ringold, G.: Mol. and Cell Biol. Jan., 166 (1984)
Pitha, P. M., Reyes, G. R., Raj, N. B. K., Hayward, G. S.: Expression of human Β-interferon gene in heterologous cells, in: Interferons, UCLA Symposia on Molecular and Cellular Biology, 25 (eds. Merigan, T. and Friedman, R.) p. 41, New York, Academy Press 1982
Van Brunt, J.: Biotechnology 4, 835 (1986)
Billiau, A., De Somer, P.: Clinical use of interferons in viral infections, in: Interferon and interferon inducers: Clinical application (ed. Stringfellow, D. A.) p. 114, 1980
Obert, H. J.: Clinical Trials conducted with beta-interferon. The biology of the Interferon in Germany, in: The Biology of the Interferon System (eds. De Maeyer, E., and Schellekens, H.) p. 469, Amsterdam, New York, Oxford, Elsevier Science Publishers 1983
Suzuki, H.: Effect of human fibroblast interferon (Hu IFN Β) on Hbc antigen-positive chronic active hepatitis, in: Proceedings of the International Symposium on Interferons (ed. Kiishida, T.) p. 259, Japan Convention Services Inc., Osaka Branch 1983
Van Damme, J., Billiau, A.: Large scale production of Human Fibroblast Interferon, in: Methods in Enzymology 78 (ed. Pestka, S.) p. 101, New York, London 1981
Spier, R. E.: Adv. Biochem. Eng. 14, 119 (1980)
Leong, S. S., Horoszewicz, J. S.: Production and preparation of human fibroblast interferon or clinical trials, in: Methods in Enzymology 78 (ed. Pestka, S.) p. 87, New York, London 1981
Skoda, R., Pakos, V., Hörmann, A., SpÄth, O., Johansson, A.: Communicating Vessel Systems for Mass Cell Culture of Anchorage Dependent Cells, in: Develop. Biol. Standard. 42 (ed. Inter. Assoc. Biol. Standard) p. 121, Basel, S. Karger 1978
Obert, H. J., Joester, K. E.: Sources of Interferon for Clinical use: Β-Interferon from Fibroblasts, in: Interferon 4 (eds. Finter, N. B., Oldham, R. K.) p. 89, Amsterdam-New York-Oxford, Elsevier 1985
Kruse, P. F., Mediema, E.: J. Cell. Biol. 27, 273 (1965)
Mann, G. F.: PAHO Bulletin VI 33, (1972)
Van Wezel, A.: Nature 216, 64 (1967)
Katinger, D., Scheirer, W.: Mass cultivation of mammalian cells in an airlift fermentor, in: Develop. Biol. Standard. 42 (ed. Intern. Ass. Biol. Standard.) p. 111, Basel, S. Karger 1979
Berg, G. J.: An integrated system for large-scale cell culture, in: Develop. Biol. Standard. 60 (ed. Intern. Ass. Biol. Standard.) Basel, S. Karger 1984
Knazek, R. A.: Science 178, 65 (1972)
Knight, E.: Proc. Natl. Acad. Sci. U.S.A. 73, 520 (1967)
Berthold, W., Tan, C., Tan, Y. H.: J. Biol. Chem. 253, 5206 (1978)
Heine, J. W., De Ley, M., Van Damme, J., Billiau, A., De Somer, P.: Ann. N.Y. Acad. Sci. 350, 364 (1980)
Friesen, N. J., Stein, S., Evinger, M., Familletti, P. C., Moschera, J., Meienhofer, J., Shively, J., Pestka, S.: Arch. Biochem. Biophys. 206, 432 (1981)
Knight, E., Fahey, O.: J. Biol. Chem. 256, 3609 (1981)
Novick, D., Eshhar, Z., Gigi, O., Marks, Z., Revel, M., Rubinstein, M.: J. Gen. Virol. 64, 905 (1983)
Berg, K., Ogburn, C. A., Paucker, K., Mogensen, K. E., Cantell, K.: J. Immunol. 114, 640 (1975)
Hochkeppel, H. K., Menge, V., Collins, J.: Nature 291, 500 (1981)
Zoon, K.: Interferon Test Procedure: Points to consider in the production and testing of interferon intended for investigational use in humans, Office of Biologies National Center for Drugs and Biologies, July 28, 1983
Mun, H. NG., Vilcek, J.: Adv. Prot. Chem. 26, 173 (1972)
Edy, V. G., Braude, I. A., De Clercq, E., Billiau, A., De Somer, A.: J. Gen. Virol. 33, 517 (1976)
Heine, K. J. W., Billiau, A.: Purification of human fibroblast interferon by adsorption to controlled-pore glass and zinc-chelate chromatography, in: Methods in Enzymology, 78 (ed. Pestka, S.) p. 448, New York, London, 1981
Heine, J. W., Van Damme, J., De Ley, M., Billiau, A., De Somer, P.: J. Gen. Virol. 54, 47 (1981)
Edy, V. G., Billiau, A., De Somer, P.: J. Biol. Chem. 252, 5939 (1977)
Havell, E. A., Vilcek, J.: Antimicrob. Agents Chemothe. 2, 476 (1972)
Allison, L. M. C., Mann, G. F., Perkins, F. T., Zuckerman, A. J.: J. Biol. Standard. 9, 185 (1981)
Code of Federal Regulations 21: Parts 600–789 Paragraph 630. 13 (C.2). Revised April 1, 1983
WHO Tech. Rep. Ser. 610, 54 (1977)
WHO Tech. Rep. Ser. 658, 313 (1981)
Morandi, M., Stangheilini, L., Valeri, A.: Problems involved in the large-scale production of biological products, such as Β-interferon, using diploid fibroblast cells as substrate, in: Develop. Biol. Standard. 60 (ed. Intern. Ass. Biol. Standard.) p. 405, Basel, S. Karger, 1984
Rubinstein, S., Familletti, P. C., Pestka, S.: J. Virol. 37, 755 (1981)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag
About this paper
Cite this paper
Morandi, M., Valeri, A. (1988). Industrial scale production of Β-interferon. In: Bioprocesses Including Animal Cell Culture. Advances in Biochemical Engineering/Biotechnology, vol 37. Springer, Berlin, Heidelberg. https://doi.org/10.1007/BFb0009177
Download citation
DOI: https://doi.org/10.1007/BFb0009177
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19004-2
Online ISBN: 978-3-540-38899-9
eBook Packages: Springer Book Archive